It is an elegant concept. Sometimes, helping tissue recover may require not only introducing something new, but also improving the environment in which the body's existing cells operate.
How Could an Injectable Hydrogel Help the Heart?
The word hydrogel may bring to mind a soft, transparent substance, but these materials can be engineered to perform highly specialized biological functions.
Hydrogels are networks of molecules capable of retaining substantial amounts of water. Depending on their composition and structure, they can be designed to resemble certain properties of biological tissues.
Researchers can modify their mechanical strength, degradation rate, chemical composition, and interactions with surrounding cells.
In regenerative medicine, these characteristics make hydrogels useful candidates for delivering biological molecules, supporting cells, and providing temporary structural assistance to injured tissue.
The research area is described in detail in a 2023 review published in the journal Bioengineering, available through PubMed Central. The authors discuss how injectable hydrogels may help with cardiac repair by delivering therapeutic substances locally and providing support within injured regions.
For Ferrer's project, the central idea is relatively straightforward.
After a heart attack, the injured area becomes part of a complex healing process involving inflammation, cell death, scar formation, and changes in the structure of the heart.
An appropriately designed hydrogel could potentially help influence this environment.
For example, a biomaterial might provide temporary structural support, preserve useful biological signals, or encourage interactions that are more favorable to repair. Depending on the material, it might also help regulate local inflammation or influence the formation of blood vessels.
These are potential mechanisms investigated across the broader field of hydrogel-based cardiac therapies. They should not automatically be interpreted as proven effects of Ferrer's specific formulation.
The exact biological effects, optimal dose, timing, and delivery method must be established through carefully controlled experiments.
Nevertheless, the approach offers a promising research direction because it seeks to work with the biology of the injured heart rather than treating the organ as an isolated mechanical pump.
Why the Amniotic Membrane Is Interesting to Scientists
The use of placental tissue may sound unusual, but it has a scientific foundation.
The amniotic membrane contains extracellular matrix components and biologically active substances that have attracted attention for their potential roles in tissue healing.
Researchers have investigated amniotic membrane-derived materials in areas such as wound healing and tissue engineering. Its biological properties make it a candidate for applications where scientists want to support repair without necessarily transplanting living cells.
One important study was published in Advanced Healthcare Materials in 2020 under the title “Development of Injectable Amniotic Membrane Matrix for Post-Myocardial Infarction Tissue Repair”.
The researchers developed an injectable matrix derived from human amniotic membrane. They processed the tissue to remove cells while retaining elements of its extracellular matrix, then engineered the resulting material to form a gel around body temperature.
The team tested the material in laboratory experiments and in rats that had experienced experimentally induced heart attacks.
The results were encouraging. The animals receiving the amniotic membrane matrix showed improved measures of cardiac contractility and reduced fibrosis compared with the control group.
Fibrosis refers to the formation of fibrous connective tissue, which can replace damaged tissue but does not perform the same functions as healthy heart muscle.
The study demonstrated that an amniotic membrane-derived injectable material could be developed and investigated as a potential approach to post-heart-attack repair.
However, there is an important distinction: this was a separate research project, conducted by a team associated with universities in California. It provides scientific context for the broader approach, but it should not be confused with proof that Ferrer's own formulation has achieved identical results.
That distinction is essential when evaluating emerging medical technologies.
Similar concepts can provide valuable background evidence, but each formulation must establish its own safety, effectiveness, and reproducibility.
What Makes the Research Different From a Stem Cell Treatment?
Regenerative medicine includes several approaches that are sometimes grouped together despite having different mechanisms.
Stem cell therapies seek to use cells, or substances produced by cells, to influence healing or potentially replace damaged tissue.
Tissue-engineering approaches may use scaffolds to support cells and organize the environment in which tissue develops.
Hydrogels can be used in either type of strategy, but they can also be investigated as biomaterials in their own right.
According to reporting by Argentina's newspaper La Nación in August 2026, Ferrer's team is developing a hydrogel based on the matrix of the amniotic membrane, with the intention of supporting repair in damaged cardiac tissue. The report describes the approach as one that uses the tissue's structural material rather than stem cells as its principal component.
That distinction is scientifically meaningful.
A scaffold does not need to become a functioning heart cell itself to have a biological effect. Instead, it may influence how nearby cells interact with the damaged region.